Metabolomics refers to the identification as well as the quantification of the cellular metabolites with the help of improved, efficient and refined analytical techniques. Metabolomics comprises of the usage of statistical as well as the multi variant techniques for the better understanding of the data as well as information mining of resources. Metabolomics helps in providing a more accurate and through functional info of the physiological state of a living organism and is majorly employed in bridging the overall gap between the genotype and phenotype by providing a complete, total and overall view of the functioning of a cell as well as the identification of novel alterations in various metabolites. Several advanced and modern analytical procedures are deployed and are used to check the metabolites in diverse organisms, fluids or tissues.
The rising number of government initiatives and increasing governmental funding and organizational initiatives majorly in North America and Europe is one of the major aspects propelling the growth of the global metabolomics market. Rising necessity for enhanced development and research facilities coupled with increasing investments in technologies of toxicology among biotechnology and pharmaceutical sectors are some of the major elements accelerating the growth of the global metabolomics market. Moreover, as the personalized health care facilities helps in furnishing the required information in order to detect the onset of diseases at a relatively earlier stage, it in turn prevents the progression of disease as well as increases the overall effectiveness of healthcare system by refining the total quality, availability, and affordability, thus further driving the global metabolomics market during the forecast period.
The global metabolomics market can be categorized based on indication, technique, geography and application. Based on technique, the global metabolomics market can be categorized into detection techniques and separation techniques. Separation techniques segment can be further divided into ultra-performance liquid chromatography, gas chromatography, high performance liquid chromatography and capillary electrophoresis. The detection techniques segment can be further divided into surface based mass analysis, mass spectrometry and nuclear magnetic resource spectroscopy. Based on application, the global metabolomics market can be bifurcated into toxicology testing, drug discovery, biomarker discovery, nutrigenomics and others. Based on indication the global metabolomics market can be divided into neurology, cardiology, others and oncology. Based on geography, the global metabolomics market can be categorized into North America, Latin America, Europe, Middle East & Africa and Asia-Pacific. The robust demand especially in the Asia Pacific region is anticipated to be one of the key driving factors for the overall growth of the global market. Moreover, China is further projected to account for the highest share in the global market and is anticipated to maintain its lead in the overall demand during the forecast period. This can be attributed to rapid industrialization and increasing urbanization during the past few years. The markets in various other developing economies such as Russia, Brazil, Indonesia, Poland, Argentina, New Zealand, Korea and India among others are also expected to witness a rapid growth throughout the forecast period. In addition to this, rising per capita disposable income and surge in the global economy is another key factor which is expected to bring impetus in the growth of the global market during the forecast period.
Key players operating in the global market are concentrating on some of the major market strategies such as mergers, collaborations, partnerships and acquisitions in order to keep grip in the constantly competitive global market. Besides, they are focusing on gaining grip on the local players to support their goodwill as well as to improve their market reach in the global market. Key players involved in the manufacture of metabolomic devices include Human Metabolome Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Biocrates Life Sciences AG, Agilent Technologies, Metabolon Inc., Bruker Corporation, LECO Corporation, Bio-Rad laboratories Inc. and Shimadzu Corporation and others.
The global metabolomics market can be segmented
• Detection techniques
• Separation techniques
• Toxicology testing
• Drug discovery
• Biomarker discovery
• North America
• Latin America
• Middle East & Africa